- All sections
- C - Chemistry; metallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processes
- C12Q 1/6886 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
Patent holdings for IPC class C12Q 1/6886
Total number of patents in this class: 10937
10-year publication summary
|
326
|
416
|
858
|
1247
|
1349
|
1298
|
1388
|
1404
|
1275
|
65
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1170 |
296 |
| The Regents of the University of California | 19503 |
159 |
| Dana-Farber Cancer Institute, Inc. | 2536 |
157 |
| The Johns Hopkins University | 5529 |
148 |
| Guardant Health, Inc. | 366 |
133 |
| The General Hospital Corporation | 4645 |
125 |
| Mayo Foundation for Medical Education and Research | 3106 |
122 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3352 |
111 |
| The Board of Trustees of the Leland Stanford Junior University | 6239 |
103 |
| Memorial Sloan-Kettering Cancer Center | 1889 |
101 |
| Foundation Medicine, Inc. | 303 |
96 |
| Board of Regents, The University of Texas System | 5613 |
94 |
| The Broad Institute, Inc. | 1706 |
87 |
| Exact Sciences Corporation | 285 |
85 |
| National Cancer Center | 398 |
81 |
| Grail, LLC | 216 |
80 |
| Genentech, Inc. | 3867 |
77 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2608 |
77 |
| Toray Industries, Inc. | 6848 |
70 |
| Centre National de La Recherche Scientifique | 10091 |
67 |
| Other owners | 8668 |